Loading clinical trials...
Loading clinical trials...
Allogeneic hematopoietic stem cell transplantation (HSCT) represents a major therapeutic strategy for malignant hematologic diseases, with the number of procedures steadily increasing in France each y...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
NCT07569055 · Invasive Fungal Disease, Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
NCT07528586 · Cardiotoxicity, Anthracycline-induced Cardiotoxicity
NCT06093867 · Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
NCT07101588 · Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
NCT07191730 · Cardiotoxicity, Heart Failure, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions